# A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

> **NCT01448902** · PHASE2 · COMPLETED · sponsor: **Oxagen Ltd** · enrollment: 36 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** OC000459
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01448902
- **Lead sponsor:** Oxagen Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448902, "A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01448902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*